Please contact the doctor's office directly to verify that your particular insurance is accepted.
Schedule an Appointment
Call To Schedule Today
Connect Patient Portal
About Mitchell S.V. Elkind, MD, MS, MPhil
Mitchell Elkind, MD, MS is a tenured Professor of Neurology and Epidemiology at Columbia University Irving Medical Center, and Chief of the Division of Neurology Clinical Outcomes Research and Population Sciences (Neuro CORPS) in the Neurology Department.
Dr. Elkind received his medical degree from Harvard Medical School, and trained in Internal Medicine at Brigham and Women's Hospital and in Neurology at Massachusetts General Hospital, both in Boston, MA. He completed a fellowship in Vascular Neurology and Neuroepidemiology at Columbia University Medical Center under the mentorship of Dr. Ralph Sacco. Dr. Elkind holds a Master's degree in Epidemiology from Columbia's Mailman School of Public Health.
Dr Elkind's research focuses on stroke prevention, inflammatory and infectious biomarkers in stroke risk prediction, atrial cardiopathy, immune therapy for acute stroke, and vascular causes of cognitive aging. Dr. Elkind is the Principal Investigator of several independent investigator awards from NIH/NINDS, including the ARCADIA trial of apixaban vs aspirin for atrial cardiopathy in cryptogenic stroke; the Northern Manhattan Study (NOMAS), an epidemiological study of stroke risk factors; the Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART), a clinical trial evaluating short-term high-dose statin therapy in acute stroke; and the Levels of Inflammatory Markers in Treatment of Stroke (LIMITS) study.
Dr. Elkind also has a longstanding commitment to medical education and research training. In addition to leading the Columbia Neurology residency and fellowship programs, he serves as editor of the AHA/ASA Stroke journal's new International Stroke Early Career and Training Section (InterSECT). He runs two NIH-funded research training programs for residents and fellows. Dr. Elkind has served on several AHA/ASA committees, including 3 terms on the National Board of Directors (2014-2020), 2 terms as Chair of the ASA Advisory Committee (2016-2020), and co-chair or member of several writing committees for guidelines and scientific statements. He co-chaired the writing committee for the 2012 scientific statement on the inclusion of stroke as an outcome and risk equivalent in vascular disease risk scores, and currently serves as Chair of the stroke section of the annual statistical update. Dr. Elkind will become President of the American Heart Association July 1, 2020.
Dr. Elkind lives in New York City with his wife (novelist and children's book author Rachel Vail) 2 sons (Zachary and Liam), and a pet tortoise (Lightning).
- Vascular Neurology
- Cerebrovascular Disease
- Internship: Brigham & Women's Hospital - Harvard
- Residency: Massachusetts General Hospital
- Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
Titles & Positions
- Professor of Neurology and Epidemiology (in the Gertrude H. Sergievsky Center)
- NewYork-Presbyterian / Columbia University Irving Medical Center